Telcon RF Pharmaceutical

200230 · KOSDAQ · ₩200230 · 텔콘RF제약

₩2,150▲ ₩85 (4.12%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩43B₩38B₩36B₩28B₩38B
Cost of sales₩33B₩28B₩27B₩22B₩29B
Gross profit₩10B₩10B₩9.6B₩5.7B₩9.1B
Operating income₩719M−₩71M₩965M−₩4.1B−₩2.7B
Net income−₩11B−₩26B₩14B−₩42B−₩23B
Net income to shareholders−₩11B−₩26B₩14B−₩42B−₩23B

Balance sheet

20252024202320222021
Total assets₩157B₩154B₩140B₩119B₩168B
Current assets₩58B₩26B₩33B₩23B₩37B
Cash and equivalents₩26B₩3.3B₩8.5B₩9.7B₩23B
Total liabilities₩48B₩70B₩35B₩35B₩61B
Current liabilities₩46B₩70B₩35B₩34B₩60B
Borrowings₩32B₩55B₩26B₩29B₩54B
Total equity₩109B₩83B₩105B₩84B₩107B
Shareholders' equity₩109B₩83B₩104B₩84B₩107B

Cash flow

20252024202320222021
Cash from operations₩1.7B₩1.2B−₩1.1B−₩2.1B−₩359M
Capital spending₩320M₩5B₩1.9B₩819M₩2.3B
Free cash flow₩1.3B−₩3.7B−₩3B−₩2.9B−₩2.6B

Consolidated where available. Amounts in won.

Also known as: Telcon RF Pharmaceutical / 텔콘RF제약 / 200230 / KRX:200230

Source: KRX statistical information